AD/PD™ 2019, Lisbon - Plenary Sessions

Plenary Sessions

 AD/PDTM 2019 PLENARY SPEAKERS:

Wedenesday March 27

PLENARY 1: TREM2 – FROM BASIC MECHANISMS TO HUMAN PATIENTS
Christian Haass, Germany
Biomedizinisches Centrum (BMC), Biochemie & Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) e.V. Feodor-Lynen Strasse 17; 81377 München; Germany

PLENARY 2: HOW MICROGLIA WIRE AND UNWIRE THE BRAIN
Beth Stevens, USA
Boston Children's Hospital; Harvard Medical School, The Broad Institute

PLENARY 3: WHAT WORKS AND DOESN'T WORK IN AD
Rachelle Doody, Switzerland
F. Hoffman-La Roche Ltd


THURSDAY, MARCH 28, 2019

PLENARY 4: ROLE OF ALPHA-SYNUCLEIN AND LESSONS LEARNED FROM THE BRAIN
Glenda Halliday, Australia
Neuroscience Research Australia


FRIDAY, MARCH 29, 2019

PLENARY 5: THE CELL BIOLOGY OF SYNAPSE FORMATION AND SYNAPSE DEGENERATION
Thomas C. Sudhof, USA - 2013 Nobel Prize in Physiology or Medicine 
Avram Goldstein Professor, Dept. of Molecular & Cellular Physiology, Stanford University School of Medicine
Stanford CA


SATURDAY, MARCH 30, 2019

PLENARY 6: MODULATION OF Ab DEPOSITION BY THE MICROBIOME
Sam Sisodia, USA
Thomas Reynolds Sr Family Professor of Neurosciences.  Departments of Neurobiology and Neurology, University of Chicago


SUNDAY, MARCH 31, 2019

PLENARY 7: THE UBIQUITIN PROTEOLYTIC SYSTEM – A MAJOR ARM OF THE PROTEIN QUALITY CONTROL MACHINERY IN HEALTH AND DISEASE
Aaron Ciechanover, Israel - 2004 Nobel Prize in Chemistry
Technion Integrated Cancer Center (TICC), The Rappaport Faculty of Medicine and Research Institute & Technion-Israel Institute of Technology 

PLENARY 8: BIOMARKER ACTIVITIES IN Α-SYNUCLEN AGGREGATION DISORDERS
Brit Mollenhauer, Germany
Paracelsus-Elena-Klinik, Kassel and University Medical Center Goettingen, Department of Neurology, Germany